Summary
We have prepared a strain of Escherichia coli that expresses both the HIV protease and a Tet protein which has been modified to contain the HIV protease recognition sequence. When the protease is expressed, the bacteria will not grow in the presence of tetracycline. However, when the protease is inhibited the bacteria can grow in tetracycline containing media (Block and Grafstrom 1990). We have selected spontaneously arising Tet resistant mutants and have screened them for those that could be producing an inhibitor of HIV protease. The problems in the construction of this strain and the characterization of the various Teti mutants are discussed.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Ames, B.N., McCann, J., and Yamasaki, E., 1975, Methods for detecting carcinogens and mutagens with the Salmonella/mammalian-microsome mutagenicity test, Mutation Research, 31:347–364.
Ashby, J., and Tennant R.W., 1988, Chemical structure, Salmonella mutagenicity and extent of carcinogenicity as indicators of genotoxic carcinogens among 222 chemicals tested on rodents by the U.S. NCl/NTP, Mutation Research 204:17–115.
Backman, K. and Boyer, H.W., 1983, Tetracycline resistance determined by pBR322 is mediated by 1 polypeptide, Gene 26:197–203.
Barany, F., 1985, Two-codon insertion mutagenesis of plasmid genes by using single-stranded hexameric oligonucleotides, Proc. Natl. Acad. Sci. USA 82:4202–4206.
Baum, E.Z., Bebernitz, G.Z., and Gluzman, Y., 1990a, Beta galactosidase containing a human immunodeficiency virus protease cleavage site is cleaved and inactivated by human immunodeficiency protease, Proc. Natl. Acad. Sci. USA 87:10023–10027.
Baum, E.Z., Bebernitz, G.A., and Gluzman, Y., 1990b, Isolation of mutants of human immunodeficiency virus protease based on the toxicity of the enzyme in Escherichia coli, Proc. Natl. Acad.Sci. USA 87:5573–5577.
Bjornsti, M.A., Benedetti, GA., Viglianti, A., and Wang, J.C., 1989, Expression of human DNA topoisomerase I in yeast cells lacking yeast DNA topoisomerase I: Restoration of sensitivity of the cells to the antitumor drug camptothecin, Cancer Research 49:6318–6323.
Block, T.M., and Grafstrom R.H., 1990, Novel bacteriological assay for the detection of potential antiviral agents, Antimicrob. Agents and Chemo. 34:2337–2341.
Borel, J.F., Feurer, C., Magnee, C., and Stahelin, H., 1977, Effects of the new anti-lymphocytic peptide cyclosporin A in animals, Immunol. 32:1017–1025.
Cairns, J., Overbaugh, J., and Miller, S., 1988, The origin of mutants, Nature 335:142–145.
Curiale, M.S., McMurry L.M., and Levy, S.B., 1984, Intracistronic complementation of the tetracycline resistance membrane protein of Tn10, J. Bacteriol. 157:211–217.
Cwirla, S.E., Peters, E.A., Barrett, R.W., and Dower, W.J., 1990, Peptides on phage: A vast library of peptides for identifying ligands, Proc. Natl. Acad. Sci. USA 87:6378–6382.
Debouck, C., Gorniak, J.G., Strickler, J.E., Meek, T.D., Metcalf, B.W., and Rosenberg, M., 1987, Human immunodeficiency virus protease expressed in Escherichia coli exhibits autoprocessing and specific maturation of the gag precursor, Proc. Natl. Acad.Sci. USA 84:8903–8906.
DeClercq, KE., 1990, Targets and strategies for the antiviral chemotherapy of AIDS, TIPS 11:198–205.
Dreyer G.B., Metcalf, B.W., Tomaszek, T.A., Jr., Carr, T.J., Chandler, A.C., III, Hyland, L., Fakhouryk, S.A., Magnard, V.W., Moore, M.L., Strickler, J.F., Debouck, C., and Meek, T.D.1989, Inhibition of HIV-1 protease in vitro: rational design of substrate analogue inhibitors, Proc. Natl.Acad. Sci. USA 86:9752–9756.
Evnin, L.B., Vazquez, J.R., and Craik, C.S., 1990, Substrate specificity of trypsin investigated by using a genetic selection, Proc. Natl. Acad. Sci. USA 87:6659–6663.
Hall, B., 1990, Spontaneous point mutations that occur more often when advantageous than when neutral, Genetics 126:5–16.
Hansen, J., Billich, S., Schulze, T., Sukrow, S., and Moelling, K., 1988, Partial purification and substrate analysis of bacterially expressed HIV protease by means of monoclonal antibody, EMBO J. 7:1785–1791.
Harley, C.B., Laurie, J., Betlack, M., Crea, R., Boyer H.W., and Hedgpeth, J., 1988, Transcription initiation a the tet promoter and effect of mutations, Nucleic Acids Res. 16:7269–7285.
Harley, C.B., Laurie, J., Boyer, H.W., and Hedgpeth, J., 1990, Reiterative copying by the E. coli RNA polymerase during transcription initiation of mutant pBR322 tet promoters, Nucleic Acids Res. 18:547–552.
Huse, W.D., Sastry, L., Iverson, S.A., Kong, A.S., Alting, S., Mees, M., Burton, D.R., Benkovic, Si., and Lerner, R.A.,1989, Generation of a large combinational library of the immunoglobulin repertoire in phage lambda, Science 246:1275–1281.
Ivanoff, L.A., Towatari, T., Ray, J., Korant, B.D., and Petteway, S.R., 1986, Expression and site specific mutagenesis of the poliovirus 3C protease in Escherichia coli, Proc. Natl. Acad. Sci. USA 83:5392–5396.
Kadonaga, J.T., Carner, K.R., Masiarz, F.R., and Tijan, R., 1987, Isolation of cDNA encoding transcription factor Spl and functional analysis of the DNA binding domain, Cell 51:1079–1090.
Kholberg, R., 1991, Critics call for a smarter way to screen for drugs, J. NIH Res. 3:25–26.
Kohl, N.E., Emini, E.A., Schleif, W.A., Davis, L.J., Heimbach, J.C., Dixon, R.A.F., Scolnick, E.M., and Sigal, I.S., 1988, Active immunodeficiency virus protease is required for viral infectivity, Proc. Natl. Acad. Sci. USA 85:4686–4690.
Korant, B., 1990, AIDS Research and Reference Reagent Program Catalog, U.S. Department of Health and Human Services, p.51 (January).
Krausslich, H.G., Schneider, H., Zybarth, G., Carter, C.A., and Wimmer, E., 1988, Processing of in vitro synthesized gag precursor proteins of human immunodeficiency virus (HIV) type-1 by HIV protease generated in Escherichia coli, J. Virol. 62:4393–397.
Legrice, S.F.J., Mills, J., and Mous, J., 1988, Active site mutagenesis of the AIDS virus protease and its alleviation by trans complementation, EMBO J. 7:2547–2553.
Marshall, B., Morrissey, S., Flynn, P., and Levy, S.B., 1986, A new tetracycline resistant determinant, class E isolated from Enterobacteriaceae, Gene 50:111–117.
McCann, J., Choi, E., Yamasaki, E., and Ames, B.N., 1975,Detection of carcinogens as mutagens in the Salmonella/microsome test: Assay of 300 chemicals, Proc. Natl. Acad. Sci. USA 72:5135–5139.
McMurry, L., Petrucci, R.E., and Levy, S.B., 1980, Active efflux of tetracycline encoded by four genetically different tetracycline resistance determinants of Escherichia coli, Proc. Natl. Acad. Sci. USA 77:3974–3977.
McQuade, T.J., Tomasselli, A.G., Liu, L., Karacostas V., Moss, B., Sawyer, T.K., Heinrikson, R.L., Tarpley, W.G., 1990, A synthetic HIV-protease inhibitor with antiviral activity arrests HIV-like particle maturation, Science 247:454–456.
Middleman, E., Luce, J., and Frei, E., 1971, Clinical trials with adriamycin, Cancer 28:844–850.
Miller, M., Schneider, J., Sathyanarayana, B.K., Toth, M.V., Markshall, G.R., Clawson, L., Selk, L., Kent, S.B.H., and Wlodawer, A.,1989, Structure of complex of synthetic HIV-1 protease with a substrate-based inhibitor at 2.3 A resolution, Science 246:1149–1151.
Mitsuya, H., Yarchoan, R., and Broder, S., 1990, Molecular targets for AIDS therapy, Science 249:1533–1544.
Moore, M.L., Bryan, W.M., Fakhoury, S.A., and Maagard, V.M., Huffman, W.F., Dayton, B.D., Meek, T.D., Hyland, L., Dreyer, G.B., Metcalf, B.W., Strickler, J.E., Gorniak, J.G., and Debouck, C., 1989, Peptide substrates and inhibitors of the HIV-1 protease, Biochem. Biophys. Res. Comm. 159:420–425.
Pauwels, R., Andries, K., Desmyter, J., Schols, D., Kukla, M.J., Breslin, H.J., Raeymaeckers, A., Van Gelder, J., Woestenborghs, R., Heykants, J., Schellekens, K., Janssen, M.A.C., DeClerq, E., and Janssen, P.A.J., 1990, Potent and selective inhibition of HIV-1 replication in vitro by a novel series of TIBO derivatives, Nature 343:470–474.
Roberts, N.A., Martin, J.A., Kinchington, D., Broadhurst, A.V., Craig, J.C., Duncan, I.B., Galpin, S.A., Handa, B.K., Krohn, J.K.A., Lambert, R.W., Merrett, J.H., Mills, J.S., Parkes, K.B.B., Redshaw, S., Ritchie, A.J., Taylor, D.L., Thomas, G.J., Machin, P.J., 1990, Rational design of peptide-based HIV proteinase inhibitors, Science 248:358–361.
Rubin, R.A., and Levy, S., 1990, Interdomain hybrid Tet proteins confer tetracycline resistance only when they are derived from closely related members of the tet gene family, J. Bacteriol. 172:2303–2312.
Seelmeir, S., Schmidt, H., Turk, V., and von der Helm, K., 1988, Human immunodeficiency virus has an aspartic-type protease that can be inhibited by pepstatin A, Proc. Natl. Acad. Sci. USA 85:6612–6616.
Sidwell, R.W., Dixon, G.J., Schabel, F.M., 1968, Antiviral activity of 9-beta-Darabinofuranosyl adenine, Antimicrob. Agent. Chemo. 8:148–154.
Yang, H.L., Zubay, kG., and Levy, S., 1976, Synthesis of a R plasmid associated with tetracycline resistance is negatively regulated, Proc. Natl. Acad. Sci. USA 73:1509–1512.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1992 Springer Science+Business Media New York
About this chapter
Cite this chapter
Grafstrom, R.H., Zachariasewycz, K., Brigandi, R.A., Block, T.M. (1992). Genetically Engineered Bacteria to Identify and Produce Anti-Viral Agents. In: Block, T.M., Jungkind, D., Crowell, R.L., Denison, M., Walsh, L.R. (eds) Innovations in Antiviral Development and the Detection of Virus Infections. Advances in Experimental Medicine and Biology, vol 312. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-3462-4_3
Download citation
DOI: https://doi.org/10.1007/978-1-4615-3462-4_3
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-6533-4
Online ISBN: 978-1-4615-3462-4
eBook Packages: Springer Book Archive